A Phase 2 interventional study of HRS5580 and HRS5580 in Preventing of Postoperative Nausea and Vomiting in Adults, sponsored by Fujian Shengdi Pharmaceutical Co., Ltd.. Completed at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-20.
Sponsored by Fujian Shengdi Pharmaceutical Co., Ltd. (part of Jiangsu HengRui Medicine Co., Ltd.) · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Postoperative Nausea and Vomiting with a site in China — 14 open to participants now, 15 under way, none of them phase 3. Postoperative Nausea and Vomiting · China.
Among the 56 studies in Postoperative Nausea and Vomiting with a site in China, this one is the 17th largest by enrollment of the 44 interventional ones that give a count, is one of 10 that started in 2024, is one of 2 in phase 2, and was the 40th registered.
638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.
Browse Postoperative Nausea and Vomiting studies →14 of the 56 studies in Postoperative Nausea and Vomiting with a site in China are open now. Recruiting first, the newest first:
General Hospital of Ningxia Medical University · Sites in China
Ages 18–65
Shanghai Chest Hospital · Sites in China
Ages 18+
Xuanwu Hospital, Beijing · Sites in China
Ages 18–65
Zhejiang University · Sites in China
Ages 18–65 · Women only
Affiliated Hospital of Nantong University · Sites in China
Ages 18–65 · Women only
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 65 Postoperative Nausea and Vomiting studies recruiting now, 22 (34%) set no upper age limit and 37 (57%) stop at 75 or younger; 14 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 10 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 235 is above the median of 112 across 529 interventional studies indexed under Postoperative Nausea and Vomiting.
Median enrollment 200 across the 44 interventional studies, 784 across the 12 observational. Of the 33 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 56 have an industry lead sponsor. The 10 most frequent:
This study is registered under Fujian Shengdi Pharmaceutical Co., Ltd., one of the names counted as Jiangsu HengRui Medicine Co., Ltd.. Under that name alone:
Fujian Shengdi Pharmaceutical Co., Ltd. is the lead sponsor of 66 studies on the registry; 24 are open to participants now.
Jiangsu HengRui Medicine Co., Ltd. has 1 study filed under Postoperative Nausea and Vomiting — fewer than ten, so there is no comparison to draw.
6 of the studies in Postoperative Nausea and Vomiting with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06997419Beijing Tiantan HospitalDexamethasone Palmitate for PONV After Open Surgery | 2026-11-30 |
| NCT07271147Affiliated Hospital of Nantong UniversityEffects of taVNS Combined With Dexmedetomidine on POVN | 2026-12-01 |
| NCT06988124Beijing Tiantan HospitalDexamethasone Palmitate for PONV After Craniotomy | 2027-05-01 |
| NCT07643298General Hospital of Ningxia Medical UniversityEffect of Lidocaine Through Gastric Tube on PONV | 2027-06-30 |
| NCT07479446Xuanwu Hospital, BeijingOliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery | 2027-08-31 |
Add all 6 to your calendar (.ics) → With an account.
Among the 56 studies in Postoperative Nausea and Vomiting with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is being conducted to evaluate the efficacy, and safety of HRS5580 for preventing of postoperative nausea and vomiting in adults. To explore the reasonable dosage of HRS5580 for postoperative nausea and vomiting.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: HRS5580
Drug: HRS5580
Drug: HRS5580
Drug: Ondansetron
Drug: blank preparation
HRS5580; low dose
HRS5580; middle dose
HRS5580; middle dose
Ondansetron
blank preparation.
No vomiting rate within 72 hours after extubation
Time frame: at 72 hours after extubation
Complete response rate (defined as the proportion of subjects without vomiting and receiving no rescue therapy) at 24, 48, 72, 96, and 120 hours after extubation
Time frame: at24, 48, 72, 96, and 120 hours after extubation
No vomiting at 24, 48, 96, and 120 hours after extubation,
Time frame: at 24, 48, 96, and 120 hours after extubation
Proportion of subjects who did not experience significant nausea within 24, 48, 72, 96, and 120 hours after extubation
Time frame: at 24, 48, 72, 96, and 120 hours after extubation
Proportion of participants not receiving rescue medication within 24, 48, 72, 96, and 120 hours of extubation
Time frame: at 24, 48, 72, 96, and 120 hours of extubation
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jun 2024 to primary completion in Oct 2024, 4 months.
Of 17 phase 2 interventional studies under Postoperative Nausea and Vomiting, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 29. This study's 4 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Postoperative Nausea and Vomiting →
Fujian Shengdi Pharmaceutical Co., Ltd. →